- Politics Democrats are suddenly eyeing a valuable pharma asset: its patents
- First Opinion Patent abuse is driving up drug prices. Just look at Lantus
- Pharmalot CVS boasts that a new pricing model will lower drug costs for health plans. Will it?
- The Readout LOUD LISTEN: Using the word ‘cure,’ an FDA loophole, & making biotech history
- In the Lab The ‘CRISPR babies’ experiment was more flawed than scientists first realized
- First Opinion Overzealous use of the CDC’s opioid prescribing guideline is harming pain patients
- In the Lab A shot-in-the-dark email leads to a century-old family treasure — and hope of cracking a deadly flu’s secret
- First Opinion Physicians aren’t ‘burning out.’ They’re suffering from moral injury
-
- Hospitals A new way to curb harmful medical errors: talk more to patients and families
- First Opinion Climate change is speeding up the spread of Lyme disease
